Papers
3
Total Citations
86
H-Index
3
About
Dr. William Tabayoyong is a urologic oncologist and surgeon-scientist whose research focuses on optimizing surgical outcomes for patients with kidney cancer, particularly through the use of robotic-assisted technologies. His most impactful work, a 2015 study with 72 citations, leveraged the National Cancer Database to analyze variation in surgical margin status across different partial nephrectomy approaches for small renal masses, providing critical population-level insights into oncologic safety. Dr. Tabayoyong is also at the forefront of evaluating next-generation surgical platforms; his 2022 study on skill transfer between multiport and single-port robotic systems (10 citations) is helping define training pathways for the da Vinci SP platform. Most recently, he has explored the role of artificial intelligence in surgical planning, demonstrating in a 2023 study (4 citations) that three-dimensional virtual models (IRIS™) can accurately predict intraoperative findings during robot-assisted partial nephrectomy. This work bridges preoperative imaging and real-time surgical execution, promising to enhance precision in nephron-sparing surgery. Dr. Tabayoyong’s contributions are shaping both the evidence base for surgical decision-making and the integration of emerging technologies into urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3